CHICAGO, Oct. 19, 2016 -- Accretive Health, Inc. (OTC Pink:ACHI) today announced it expects to release its financial results for the three months ended September 30, 2016 after market close on Wednesday, November 2, 2016.
Accretive Health’s management team will host a conference call on November 2 at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results and business outlook. To participate, please dial 877-880-5884 (631-601-2894 outside the U.S. and Canada) using conference code number 1300961. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at www.accretivehealth.com.
About Accretive Health
Accretive Health is a leading provider of revenue cycle services and Physician Advisory Services to healthcare providers. Accretive Health’s mission is to help healthcare providers strengthen their financial stability so they can deliver better care at a more affordable cost to the communities they serve, increasing healthcare access for all. Accretive Health’s distinctive operating model includes people, processes, and sophisticated integrated technology and analytics that help customers realize sustainable improvements in their operating margins and improve the satisfaction of their patients, physicians, and staff. Accretive Health’s customers typically are multi-hospital systems, including faith-based or community healthcare systems, academic medical centers and independent ambulatory clinics, and their affiliated physician practice groups.
Contact: Accretive Health, Inc. Investor and Media Relations: Atif Rahim 312.324.5476 [email protected]


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



